Dimensional Fund Advisors LP Boosts Holdings in TScan Therapeutics, Inc. (NASDAQ:TCRX)
Dimensional Fund Advisors LP increased its position in TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 108.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 280,028 shares of the company’s stock after purchasing an additional 145,731 shares during the period. Dimensional Fund Advisors LP’s holdings in TScan Therapeutics were worth $851,000 as of […]
